Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01863082
Other study ID # 2010/15649-4
Secondary ID
Status Recruiting
Phase N/A
First received May 20, 2013
Last updated March 19, 2014
Start date November 2011
Est. completion date December 2014

Study information

Verified date March 2014
Source University of Sao Paulo
Contact Lais GB Cruz
Phone +5511988811375
Email laligbcruz@yahoo.com.br
Is FDA regulated No
Health authority Brazil: National Committee of Ethics in Research
Study type Interventional

Clinical Trial Summary

patients with resistant hypertension will be submitted to an exercise protocol in a heated pool for three months


Description:

pacient´s blood pressure behavior will be compared before and after intervention


Recruitment information / eligibility

Status Recruiting
Enrollment 28
Est. completion date December 2014
Est. primary completion date August 2014
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 40 Years to 65 Years
Eligibility Inclusion Criteria:

- patients with uncontrolled blood pressure despite concurrent use of 3 antihypertensive agents, including a diuretic, or the need for more than 3 medications to control blood pressure

Exclusion Criteria:

- poor adherence to the treatment

- obesity

- diabetes

- smokers

- secondary causes of hypertension

- motor disabilities to perform the training

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Other:
exercise
practice of physical exercise

Locations

Country Name City State
Brazil Heart Institute of São Paulo University Medical School São Paulo

Sponsors (2)

Lead Sponsor Collaborator
University of Sao Paulo Fundação de Amparo à Pesquisa do Estado de São Paulo

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Primary blood pressure value participants will be followed for the duration of the exercise protocol, an expected average of 12 weeks Change from Baseline in Blood Pressure at 3 months Yes
See also
  Status Clinical Trial Phase
Recruiting NCT02385864 - CPAP Effect on Blood Pressure and Arterial Stiffness in Obstructive Sleep Apnea Patients With Resistant Hypertension N/A
Completed NCT01833429 - Autonomic Dysfunction in Resistant Hypertension N/A
Completed NCT02426099 - Efficacy of Spironolactone in Cameroonian Diabetic Patients With Resistant Hypertension Phase 4
Recruiting NCT02623036 - The Use of Ambulatory Blood Pressure Monitors to Assess Angiotensin Converting Enzyme Inhibitors Phase 1
Completed NCT02587533 - Peripheral Chemoreflex/Arterial Baroreflex Interaction in Patients With Electrical Carotid Sinus Stimulation N/A
Terminated NCT03730519 - UK Registry for Baroreflex Activation Therapy N/A
Active, not recruiting NCT05017935 - RADIANCE Continued Access Protocol N/A
Completed NCT01520506 - Rapid Renal Sympathetic Denervation for Resistant Hypertension N/A
Active, not recruiting NCT02369081 - Optimum Treatment for Drug-Resistant Hypertension Phase 4
Withdrawn NCT04542681 - MANP in African Americans With Hypertension Phase 1
Completed NCT05395403 - Use of Automated Office Blood Pressure Monitoring N/A
Recruiting NCT02057783 - Physical Activity Program for Reducing Blood Pressure in Sleep Apnea Patients With Resistant Hypertension N/A
Completed NCT01630928 - Renal Sympathetic Denervation and Potential Effects on Glucose Metabolism and Cardiovascular Risk-Factors N/A
Completed NCT01848275 - Full Length Versus Proximal Renal Arteries Ablation N/A
Completed NCT01062763 - The Effect of Spironolactone on Blood Pressure in Type-2 Diabetics With Resistant Hypertension Phase 3
Completed NCT01834118 - Reintervention-study After Previous Renal Denervation in Non-responding Patients With Severe Hypertension N/A
Active, not recruiting NCT01703780 - The Diagnosis and Treatment of Resistant Hypertension, the Prevalence and the Prognosis N/A
Not yet recruiting NCT02042066 - Safety and Efficacy Study of Extracorporeal Shockwave Therapy in the Treatment of Patients With Resistant Hypertension Phase 1
Completed NCT02667912 - Distal Renal Denervation N/A
Recruiting NCT00994617 - Monotherapy Versus Dual Therapy for Initial Treatment for Hypertension Phase 4